Subscribe to RSS
DOI: 10.1055/s-2007-977693
© Georg Thieme Verlag KG Stuttgart · New York
Relative Hypoleptinemia in Poorly Controlled Patients with Type 1 Diabetes
Publication History
                     received 4. 10. 2006
                     
                     accepted 22. 1. 2007
                     
Publication Date:
29 May 2007 (online)
Introduction
Insulin sensitivity is strictly related to body fat mass. Several studies in type 2 diabetes (T2DM) demonstrated that insulin regulates leptin (Lep) per se, regardless of adiposity [1] [2]. On the contrary, plasma adiponectin (Apn), another molecule specifically secreted from adipocytes, is negatively correlated with insulin resistance and body mass index (BMI) [3] [4]. Unlike the HOMA-IR, an index of insulin resistance, the adiponectin/leptin ratio (A/L ratio) is not influenced by fasting glucose plasma levels and could be considered a sensitive and reliable marker of insulin resistance in T2DM. Type 1 diabetes mellitus (T1DM) is an organ-specific autoimmune disease resulting from the T-cell mediated destruction of pancreatic β-cells, though glycemic control is also related to reduction in insulin sensitivity. Although it is well known that adipocytokines, principally Lep, may influence T-cell function [5] [6], their role in insulin sensitivity has not been sufficiently investigated in Type 1 diabetes.
References
- 1 Mohamed-Ali V, Pinkney JH, Panahloo A, Goodrick S, Coppack SW, Yudkin JS. Diabetic Med. 1997; 14 376-380
 - 2 Widjaja A, Stratton IM, Horn R, Holman RR, Turner R, Brabant G. J Clin Endocrinol Metab. 1997; 82 654-657
 - 3 Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y. Arterioscler Thromb Vasc Biol. 2000; 20 1595-1599
 - 4 Inoue M, Maehata E, Yano M, Taniyama M, Suzuki S. Metabolism. 2005; 54 281-286
 - 5 Matarese G, Sanna V, Lechler RI, Sarvetnick N, Fontana S, Zappacosta S, La Cava A. Diabetes. 2002; 51 1356-1361
 - 6 Imagawa A, Funahashi T, Nakamura T, Moriwaki M, Tanaka S, Nishizawa H, Sayama K, Uno S, Iwahashi H, Yamagata K, Miyagawa J, Matsuzawa Y. Diabetes Care. 2002; 25 1665-1666
 - 7 Unger RH. Nature. Endocrinology. 2003; 144 5159-5165
 
Correspondence
Prof. C. GiordanoMD 
         Endocrinology & Metabolism Section
         
         Università di Palermo
         
         Department of Experimental Oncology and Clinical Applications (DOSAC)
         
         Piazza delle Cliniche 2
         
         90127 Palermo
         
         Phone: +39/091/655 21 09
         
         Fax: +39/091/655 21 23
         
         Email: cgiordan@unipa.it
         
         
    
      
    